Tetra Bio-Pharma Inc. today announced the permanent appointment of Guy Chamberland, Ph.D., as CEO and CSO having most recently held the position of CEO in an interim capacity. Dr. Chamberland has more than 23 years' experience in the development of new drugs in the North American pharmaceutical industry.